Login / Signup

Evaluation of the safety, biodistribution, dosimetry of [ 18 F]AlF-NOTA-LM3 and head-to-head comparison with [ 68 Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.

Meixi LiuChao RenHaiqiong ZhangYuwei ZhangZhenghai HuangRu JiaYuejuan ChengChunmei BaiQiang XuWenjia ZhuLi Huo
Published in: European journal of nuclear medicine and molecular imaging (2024)
ClinicalTrials.gov identifier NCT06056362.
Keyphrases
  • neuroendocrine tumors
  • pet ct
  • optic nerve
  • study protocol
  • positron emission tomography
  • clinical trial
  • phase iii
  • randomized controlled trial
  • phase ii
  • computed tomography
  • optical coherence tomography